BRIEF published on 07/06/2026 at 20:05, 26 days 12 hours ago ABIONYX: Details on Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 07/06/2026 at 20:05, 26 days 12 hours ago ABIONYX Monthly Voting Rights Update Euronext Paris Share Capital Voting Rights Financial Update ABIONYX Pharma
PRESS RELEASE published on 07/06/2026 at 20:00, 26 days 12 hours ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares. Company focuses on innovative medicines development with lipid science expertise Shares Total Voting Rights ABIONYX Pharma Innovative Medicines Lipid Science
BRIEF published on 07/06/2026 at 19:19, 26 days 13 hours ago ABIONYX's Half-Yearly Review of the Liquidity Contract Liquidity Transactions TP ICAP Actions ABIONYX Pharma
BRIEF published on 06/30/2026 at 19:13, 1 month 1 day ago ABIONYX Pharma is expanding rapidly following its General Meeting ABIONYX Pharma Sepsis CER-001 General Assembly 2026 ApoA-I Platform
BRIEF published on 06/30/2026 at 19:13, 1 month 1 day ago ABIONYX Pharma Secures Funding to Advance Sepsis Treatment ABIONYX Pharma CER-001 Financial Funding Sepsis Treatment ApoA-I Platform
PRESS RELEASE published on 06/30/2026 at 19:08, 1 month 1 day ago Inside Information / Other news releases ABIONYX Pharma scales up operations after securing resources, focusing on value creation in inflammation and sepsis treatment. Updates on pivotal clinical trial, financial visibility, and scientific platform development Financial Resources Clinical Trial ABIONYX Pharma Sepsis Inflammation Treatment
BRIEF published on 06/18/2026 at 07:35, 1 month 14 days ago ABIONYX Pharma Completes Successful EUR 33 Million Financing Capital Increase Bond Financing ABIONYX Pharma Fenja Capital Sepsis Research
BRIEF published on 06/18/2026 at 07:35, 1 month 14 days ago ABIONYX Pharma successfully completes its capital increase Capital Increase Clinical Trial Bond Financing Sepsis Fenja Capital
PRESS RELEASE published on 06/18/2026 at 07:30, 1 month 14 days ago Inside Information / Other news releases ABIONYX Pharma successfully completes financing, raising EUR 33 M. Capital increase and bonds financing secured, enhancing financial position for future growth and clinical trials Financing Clinical Trials Capital Increase ABIONYX Pharma Bonds Financing
Published on 08/01/2026 at 01:20, 1 day 7 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 7 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 8 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 9 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 30 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 16 hours 9 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 12 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 13 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 1 day 11 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 13 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 14 hours ago Covivio Hotels - 2026 Half-year financial report
